Literature DB >> 358803

Structural requirements for tetracycline activity.

J R Brown, D S Ireland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 358803     DOI： 10.1016/s1054-3589(08)60483-4

Source DB:  PubMed          Journal:  Adv Pharmacol Chemother        ISSN： 0065-3144


× No keyword cloud information.
  5 in total

1.  Transport of the lipophilic analog minocycline differs from that of tetracycline in susceptible and resistant Escherichia coli strains.

Authors:  L M McMurry; J C Cullinane; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

2.  Biochemical analysis of the biosynthetic pathway of an anticancer tetracycline SF2575.

Authors:  Lauren B Pickens; Woncheol Kim; Peng Wang; Hui Zhou; Kenji Watanabe; Shuichi Gomi; Yi Tang
Journal:  J Am Chem Soc       Date:  2009-12-09       Impact factor: 15.419

3.  Susceptible Escherichia coli cells can actively excrete tetracyclines.

Authors:  L M McMurry; D A Aronson; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

4.  The pharmacokinetics of chlortetracycline orally administered to turkeys: influence of citric acid and Pasteurella multocida infection.

Authors:  R A Pollet; C E Glatz; D C Dyer
Journal:  J Pharmacokinet Biopharm       Date:  1985-06

5.  The binding of 6-demethylchlortetracycline to 70S, 50S and 30S ribosomal particles: a quantitative study by fluorescence anisotropy.

Authors:  B Epe; P Woolley
Journal:  EMBO J       Date:  1984-01       Impact factor: 11.598
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.